TREATPOLYQ

TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases

 Coordinatore EBERHARD KARLS UNIVERSITAET TUEBINGEN 

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Dr.
Nome: Holm
Cognome: Graessner
Email: send email
Telefono: +49 7071 2972285
Fax: +49 7071 295228

 Nazionalità Coordinatore Germany [DE]
 Totale costo 3˙757˙318 €
 EC contributo 3˙757˙318 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-ITN
 Funding Scheme MC-ITN
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-03-01   -   2015-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Dr.
Nome: Holm
Cognome: Graessner
Email: send email
Telefono: +49 7071 2972285
Fax: +49 7071 295228

DE (TUEBINGEN) coordinator 533˙510.00
2    H. LUNDBECK A/S

 Organization address address: Ottiliavej 9
city: VALBY
postcode: 2500

contact info
Titolo: Dr.
Nome: Karina
Cognome: Fog
Email: send email
Telefono: 4530832511

DK (VALBY) participant 281˙488.00
3    KING'S COLLEGE LONDON

 Organization address address: Strand
city: LONDON
postcode: WC2R 2LS

contact info
Titolo: Mr.
Nome: Paul
Cognome: Labbett
Email: send email
Telefono: 442078000000
Fax: +44 20 7848 8187

UK (LONDON) participant 261˙223.00
4    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

 Organization address address: The Old Schools, Trinity Lane
city: CAMBRIDGE
postcode: CB2 1TN

contact info
Titolo: Mr.
Nome: Keith
Cognome: Cann
Email: send email
Telefono: +44 1223 333543
Fax: +44 1223 332988

UK (CAMBRIDGE) participant 261˙223.00
5    LUNDS UNIVERSITET

 Organization address address: Paradisgatan 5c
city: LUND
postcode: 22100

contact info
Titolo: Dr.
Nome: Pia
Cognome: Berntsson
Email: send email
Telefono: +46 46 2221431
Fax: +46 46 2224546

SE (LUND) participant 260˙042.00
6    UNIVERSITE PARIS DIDEROT - PARIS 7

 Organization address address: RUE THOMAS MANN 5
city: PARIS
postcode: 75205

contact info
Titolo: Ms.
Nome: Muriel
Cognome: Maurice
Email: send email
Telefono: +33 1 57 27 55 48
Fax: +33 1 57 27 55 47

FR (PARIS) participant 257˙129.00
7    TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY

 Organization address address: TECHNION CITY - SENATE BUILDING
city: HAIFA
postcode: 32000

contact info
Titolo: Mr.
Nome: Mark
Cognome: Davison
Email: send email
Telefono: +972 4 829 3097
Fax: +972 4 823 2958

IL (HAIFA) participant 251˙385.00
8    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

 Organization address address: Rue Michel -Ange 3
city: PARIS
postcode: 75794

contact info
Titolo: Ms.
Nome: Michele
Cognome: Saumon
Email: send email
Telefono: +33 1 69 82 32 64
Fax: +33 1 69 82 33 33

FR (PARIS) participant 246˙392.00
9    INSTITUT CURIE

 Organization address address: 26, rue d'Ulm
city: PARIS
postcode: 75248

contact info
Titolo: Ms.
Nome: Corinne
Cognome: Cumin
Email: send email
Telefono: +33 156246620
Fax: +33 156246627

FR (PARIS) participant 246˙392.00
10    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Ms.
Nome: Riitta
Cognome: Ljungström
Email: send email
Telefono: +46 8 52487321
Fax: +46 8 339380

SE (STOCKHOLM) participant 246˙099.00
11    SIENA BIOTECH SPA

 Organization address address: Via Banchi di Sotto 34
city: SIENA
postcode: 53100

contact info
Titolo: Dr.
Nome: Laura
Cognome: Lucaroni
Email: send email
Telefono: +39 0577 381224
Fax: +39 0577 381 202

IT (SIENA) participant 240˙518.00
12    AC IMMUNE SA

 Organization address address: "Parc Scientifique EPFL, PSE B"
city: Lausanne
postcode: 1015

contact info
Titolo: Mr.
Nome: Jean-Fabien
Cognome: Monin
Email: send email
Telefono: +41 21 696 9122
Fax: +41 21 696 9120

CH (Lausanne) participant 238˙461.00
13    MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.

 Organization address address: Hofgartenstrasse 8
city: MUENCHEN
postcode: 80539

contact info
Titolo: Mr.
Nome: Manfred
Cognome: Messerschmidt
Email: send email
Telefono: +49 551 2011221
Fax: +49 551 2011331

DE (MUENCHEN) participant 222˙015.00
14    CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO

 Organization address address: UNIVERSIDADE DE COIMBRA .
city: COIMBRA
postcode: 3004 517

contact info
Titolo: Ms.
Nome: Silvia
Cognome: Sousa
Email: send email
Telefono: 351240000000
Fax: 351240000000

PT (COIMBRA) participant 211˙441.00
15    ENKAM PHARMACEUTICALS A/S

 Organization address address: "Fruebjergvej, 3"
city: COPENHAGEN
postcode: 2100

contact info
Titolo: Mr.
Nome: Morten
Cognome: Albrechtsen
Email: send email
Telefono: +45 39179715
Fax: +45 39179714

DK (COPENHAGEN) participant 0.00
16    NsGene A/S

 Organization address address: BALTORPVEJ 154
city: BALLERUP
postcode: 2750

contact info
Titolo: Dr.
Nome: Lars
Cognome: Wahlberg
Email: send email
Telefono: +45 4460 8900
Fax: +45 4460 8989

DK (BALLERUP) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

onset    sca    disease    polyq    model    diseases    protein    neurodegenerative    ataxia    network    degradation    treatment    training    basic    late   

 Obiettivo del progetto (Objective)

'Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (ALS), prion diseases as well as the group of polyglutamine diseases (polyQ). The aim of this proposal is to create a network of European partners bridging important basic mechanisms involved in proteinopathies, research of model diseases and treatment approaches. The “TreatPolyQ” network will focus on two main representatives of the polyQ diseases: Huntington’s disease as the most common polyQ disease as well as spinocerebellar ataxia type 3 (SCA3) as the most frequent autosomal-dominantly inherited ataxia. Patients suffer from a multitude of neurological symptoms including movement abnormalities with late onset and in a progressive manner. Up to now, no treatment or cure is available. The network will be consisting of a rare combination of experts from basic and translational research, including a Nobel prize laureate, four industrial partners (two medium, and two small companies, all incorporated as full participants) and academic leaders of the field. The network not only focuses on one special aspect of a disease but spans several important disease-associated mechanism as well as promising treatment strategies for HD and SCA3 (protein transport, protein folding, protein degradation via both the ubiquitin-proteasome system and autophagy), likely to be important across a range of neurodegenerative diseases. In order to implement these research projects, extensive collaborations and temporarily personnel secondments of the involved researchers will take place, enhancing interdisciplinary transfer of knowledge. Beyond the personalized local training plan for each employed researcher within the Network, there will be 4 structured courses covering aspects ranging from structural biology to protein degradation to model organisms and drug development, including soft skill training.'

Altri progetti dello stesso programma (FP7-PEOPLE)

ROOTFLOW (2014)

Dynamic cell coordination in the plant root

Read More  

PARMRC (2009)

Structural studies on the ParMRC plasmid DNA partitioning complex

Read More  

TRANSFORMERSURFACES (2012)

Dynamic Libraries for the Synthesis of New Multifunctional Silica Striped Nanoparticles

Read More